Skip to Main Content

Author Details

Laura A VanBlargan
Washington University School of Medicine
2013
43
22
PMIDPaper TitleJournal TitlePublished Year
36638211prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis.Proc Natl Acad Sci U S A2023
37804831Vertebrate-class-specific binding modes of the alphavirus receptor MXRA8.Cell2023
38039973A broadly reactive antibody targeting the N-terminal domain of SARS-CoV-2 spike confers Fc-mediated protection.Cell Rep Med2023
34846168Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains.Sci Transl Med2022
35412328Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice.Sci Transl Med2022
35679349A Powassan virus domain III nanoparticle immunogen elicits neutralizing and protective antibodies in mice.PLoS Pathog2022
35584653mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2.Med2022
35472136An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer.J Clin Invest2022
35688161mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes.Cell Rep Med2022
35484405Thermodynamically coupled biosensors for detecting neutralizing antibodies against SARS-CoV-2 variants.Nat Biotechnol2022
36618402SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patients.Front Immunol2022
35988541Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice.Cell Rep2022
35132398A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques.Med2022
35046573An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies.Nat Med2022
35016195Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.Nature2022
34901783Standardized two-step testing of antibody activity in COVID-19 convalescent plasma.iScience2022
34189528Detection of antibodies neutralizing historical and emerging SARS-CoV-2 strains using a thermodynamically coupled de novo biosensor system.bioRxiv2021
33907753A potently neutralizing anti-SARS-CoV-2 antibody inhibits variants of concern by binding a highly conserved epitope.bioRxiv2021
33594356SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodies.Res Sq2021
33535027Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization.Cell Host Microbe2021
33664494Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies.Nat Med2021
33501445Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein.bioRxiv2021
33831142Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses.J Exp Med2021
34981042An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies.Res Sq2021
34931194Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.bioRxiv2021
34610295Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity.Cell Host Microbe2021
34549976Dengue Virus Serotype 1 Conformational Dynamics Confers Virus Strain-Dependent Patterns of Neutralization by Polyclonal Sera.J Virol2021
34464596A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants.Immunity2021
34462745Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains.bioRxiv2021
34812429Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitors.Med2021
34481543A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope.Immunity2021
34153975In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains.Nature2021
34214467Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell.Cell Rep2021
34013261Common Mechanism of SARS-CoV and SARS-CoV-2 Pathogenesis across Species.bioRxiv2021
34268509Multivalent designed proteins protect against SARS-CoV-2 variants of concern.bioRxiv2021
32931734A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.Cell2020
29525521Human IFIT3 Modulates IFIT1 RNA Binding Specificity and Protein Stability.Immunity2018
30566864An mRNA Vaccine Protects Mice against Multiple Tick-Transmitted Flavivirus Infections.Cell Rep2018
28207910A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis.PLoS Pathog2017
27784796Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity.Microbiol Mol Biol Rev2016
26063422Context-Dependent Cleavage of the Capsid Protein by the West Nile Virus Protease Modulates the Efficiency of Virus Assembly.J Virol2015
26383952Dengue viruses cluster antigenically but not as discrete serotypes.Science2015
24348242The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein.PLoS Pathog2013
  • 1 - 43 of 43

Recommended Authors

Sebastian Weigang
Institute of Virology, Freiburg University Medical Center, University of Freiburg
Career Start Year 2018
Number of shared co-authors 0
James Logue
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 2017
Number of shared co-authors 8
Mir M Khalid
Gladstone Institutes
Career Start Year 2016
Number of shared co-authors 3
Paul V Thomas
Walter Reed Army Institute of Research
Career Start Year 2015
Number of shared co-authors 1
Carolina Lucas
Yale School of Medicine
Career Start Year 2014
Number of shared co-authors 1
Yi Shi
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 2014
Number of shared co-authors 0
Nicholas Dambrauskas
Center for Global Infectious Disease Research, Seattle Children's Research Institute
Career Start Year 2013
Number of shared co-authors 0
Chengjin Ye
Texas Biomedical Research Institute
Career Start Year 2013
Number of shared co-authors 2
Natalia E Ketaren
The Rockefeller University
Career Start Year 2013
Number of shared co-authors 0
Wilfredo F Garcia-Beltran
Ragon Institute of MGH
Career Start Year 2012
Number of shared co-authors 1
Natalia A Kuzmina
University of Texas Medical Branch, USA Galveston National Laboratory
Career Start Year 2012
Number of shared co-authors 9
Hongjie Xia
University of Texas Medical Branch
Career Start Year 2012
Number of shared co-authors 6
Meagan E Deming
University of Maryland School of Medicine
Career Start Year 2011
Number of shared co-authors 12
Yiska Weisblum
Rockefeller University
Career Start Year 2011
Number of shared co-authors 0
Ujjwal Rathore
University of California san francisco
Career Start Year 2010
Number of shared co-authors 2
Kenneth S Plante
University of Texas Medical Branch
Career Start Year 2009
Number of shared co-authors 19
Michael Schotsaert
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 6
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 4
Melissa M Coughlin
Centers for Disease Control and Prevention
Career Start Year 2006
Number of shared co-authors 2
David Noah Sather
Center for Global Infectious Disease Research, Seattle Children's Hospital
Career Start Year 2005
Number of shared co-authors 4
Natalie J Thornburg
Centers for Disease Control and Prevention (CDC)
Career Start Year 2003
Number of shared co-authors 15
Lingshu Wang
National Institute of Allergy and Infectious Disease, National Institute of Health
Career Start Year 2003
Number of shared co-authors 9
Fabian Schmidt
The Rockefeller University
Career Start Year 2002
Number of shared co-authors 3
Mansun Law
The Scripps Research Institute
Career Start Year 1998
Number of shared co-authors 1
Viviana Simon
Icahn School of Medicine at Mount Sinai
Career Start Year 1997
Number of shared co-authors 8
Benhur Lee
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 9
Theodora Hatziioannou
The Rockefeller University
Career Start Year 1995
Number of shared co-authors 3
Boyd L Yount
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 20
Ted M Ross
Center for Vaccines and Immunology, University of Georgia
Career Start Year 1991
Number of shared co-authors 9
Bart L Haagmans
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 11

Collaborators

Michael S Diamond
Washington University School of Medicine
Co-authored papers 35
Rita E Chen
Co-authored papers 21
James E Crowe
Vanderbilt University Medical Center
Co-authored papers 13
Pavlo Gilchuk
Vanderbilt University Medical Center
Co-authored papers 10
Adrianus C M Boon
Co-authored papers 7
Pei-Yong Shi
University of Texas Medical Branch
Co-authored papers 7
Alexandra C Walls
Co-authored papers 7
David Veesler
Co-authored papers 7
Scott A Handley
Washington University School of Medicine
Co-authored papers 6
Lauren Carter
Co-authored papers 5
Yoshihiro Kawaoka
Influenza Research Institute, University of Wisconsin
Co-authored papers 5
Larissa B Thackray
Washington University School of Medicine
Co-authored papers 5
Robert H Carnahan
Vanderbilt University Medical Center
Co-authored papers 4
David Baker
University of Washington
Co-authored papers 4
John C Kraft
Co-authored papers 3
Xuping Xie
University of Texas Medical Branch
Co-authored papers 3
Mary Jane Navarro
Co-authored papers 2
Ralph S Baric
University of North Carolina
Co-authored papers 2
Lisa E Gralinski
University of North Carolina at Chapel Hill
Co-authored papers 2
Michael L Gross
Washington University in St. Louis
Co-authored papers 2
Alexandra Sch??fer
University of North Carolina at Chapel Hill
Co-authored papers 2
Nisar Farhat
University of California los angeles
Co-authored papers 2
Galit Alter
Co-authored papers 2
Michael C Maher
Vir Biotechnology Inc.
Co-authored papers 2
Nadine Czudnochowski
University of California san francisco
Co-authored papers 2
Michael Gale
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 2
Amalio Telenti
Vir Biotechnology Inc.
Co-authored papers 2
Michael C Jewett
Northwestern University
Co-authored papers 2
Douglas A Lauffenburger
Massachusetts Institute of Technology
Co-authored papers 1
Francois Villinger
Co-authored papers 1
Release 1.2